CN104434998A - 一种治疗乳腺增生的中药 - Google Patents
一种治疗乳腺增生的中药 Download PDFInfo
- Publication number
- CN104434998A CN104434998A CN201410700984.4A CN201410700984A CN104434998A CN 104434998 A CN104434998 A CN 104434998A CN 201410700984 A CN201410700984 A CN 201410700984A CN 104434998 A CN104434998 A CN 104434998A
- Authority
- CN
- China
- Prior art keywords
- parts
- chinese medicine
- traditional chinese
- treatment
- cyclomastopathy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 64
- 210000005075 mammary gland Anatomy 0.000 title abstract description 5
- 206010020718 hyperplasia Diseases 0.000 title abstract description 3
- 238000011282 treatment Methods 0.000 claims abstract description 39
- 229940079593 drug Drugs 0.000 claims abstract description 23
- 238000002360 preparation method Methods 0.000 claims abstract description 14
- 239000007766 cera flava Substances 0.000 claims abstract description 10
- 239000000843 powder Substances 0.000 claims abstract description 7
- 241000124079 Mylabris Species 0.000 claims description 17
- 241000243684 Lumbricus Species 0.000 claims description 16
- 239000000463 material Substances 0.000 claims description 16
- 241000131808 Scolopendra Species 0.000 claims description 15
- 241000522620 Scorpio Species 0.000 claims description 15
- 239000009490 scorpio Substances 0.000 claims description 11
- 239000000203 mixture Substances 0.000 claims description 6
- 240000000249 Morus alba Species 0.000 claims description 5
- 235000008708 Morus alba Nutrition 0.000 claims description 5
- 238000010438 heat treatment Methods 0.000 claims description 5
- 238000005096 rolling process Methods 0.000 claims description 5
- 230000000694 effects Effects 0.000 abstract description 19
- 241000258920 Chilopoda Species 0.000 abstract description 3
- 241000623906 Lytta vesicatoria Species 0.000 abstract description 3
- 230000035876 healing Effects 0.000 abstract description 2
- 241000239226 Scorpiones Species 0.000 abstract 2
- 241001482963 Thamnophis Species 0.000 abstract 2
- 241001233061 earthworms Species 0.000 abstract 2
- 239000002994 raw material Substances 0.000 abstract 2
- 208000002193 Pain Diseases 0.000 description 19
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 201000010099 disease Diseases 0.000 description 12
- 235000013305 food Nutrition 0.000 description 11
- 208000024891 symptom Diseases 0.000 description 11
- 239000008280 blood Substances 0.000 description 10
- 210000000481 breast Anatomy 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 8
- 206010010904 Convulsion Diseases 0.000 description 6
- 230000036461 convulsion Effects 0.000 description 6
- 230000001737 promoting effect Effects 0.000 description 6
- 230000017531 blood circulation Effects 0.000 description 5
- 239000000796 flavoring agent Substances 0.000 description 5
- 235000019634 flavors Nutrition 0.000 description 5
- 231100000614 poison Toxicity 0.000 description 5
- 206010063409 Acarodermatitis Diseases 0.000 description 4
- 206010008190 Cerebrovascular accident Diseases 0.000 description 4
- 201000004624 Dermatitis Diseases 0.000 description 4
- 206010062717 Increased upper airway secretion Diseases 0.000 description 4
- 241000447727 Scabies Species 0.000 description 4
- 206010040943 Skin Ulcer Diseases 0.000 description 4
- 208000006011 Stroke Diseases 0.000 description 4
- 208000025865 Ulcer Diseases 0.000 description 4
- 230000006870 function Effects 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 201000007227 lymph node tuberculosis Diseases 0.000 description 4
- 230000001717 pathogenic effect Effects 0.000 description 4
- 208000026435 phlegm Diseases 0.000 description 4
- 208000005687 scabies Diseases 0.000 description 4
- 230000028327 secretion Effects 0.000 description 4
- 231100000019 skin ulcer Toxicity 0.000 description 4
- 210000000952 spleen Anatomy 0.000 description 4
- 230000035900 sweating Effects 0.000 description 4
- 239000003440 toxic substance Substances 0.000 description 4
- 231100000397 ulcer Toxicity 0.000 description 4
- 206010012735 Diarrhoea Diseases 0.000 description 3
- 206010019468 Hemiplegia Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 3
- 244000046052 Phaseolus vulgaris Species 0.000 description 3
- 241000237636 Pheretima Species 0.000 description 3
- 208000003251 Pruritus Diseases 0.000 description 3
- 208000005392 Spasm Diseases 0.000 description 3
- 201000011510 cancer Diseases 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 235000009508 confectionery Nutrition 0.000 description 3
- 239000003172 expectorant agent Substances 0.000 description 3
- 230000003419 expectorant effect Effects 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 210000004072 lung Anatomy 0.000 description 3
- 230000005906 menstruation Effects 0.000 description 3
- 230000003340 mental effect Effects 0.000 description 3
- 244000052769 pathogen Species 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- 231100000419 toxicity Toxicity 0.000 description 3
- 230000001988 toxicity Effects 0.000 description 3
- 239000003053 toxin Substances 0.000 description 3
- 231100000765 toxin Toxicity 0.000 description 3
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 239000003390 Chinese drug Substances 0.000 description 2
- 206010012335 Dependence Diseases 0.000 description 2
- 208000000571 Fibrocystic breast disease Diseases 0.000 description 2
- 206010016717 Fistula Diseases 0.000 description 2
- 208000032843 Hemorrhage Diseases 0.000 description 2
- 206010024229 Leprosy Diseases 0.000 description 2
- 208000004880 Polyuria Diseases 0.000 description 2
- NKANXQFJJICGDU-QPLCGJKRSA-N Tamoxifen Chemical compound C=1C=CC=CC=1C(/CC)=C(C=1C=CC(OCCN(C)C)=CC=1)/C1=CC=CC=C1 NKANXQFJJICGDU-QPLCGJKRSA-N 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 230000003110 anti-inflammatory effect Effects 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 208000026555 breast adenosis Diseases 0.000 description 2
- 208000030270 breast disease Diseases 0.000 description 2
- 239000000812 cholinergic antagonist Substances 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- 230000001684 chronic effect Effects 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000035619 diuresis Effects 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 230000002708 enhancing effect Effects 0.000 description 2
- 206010015037 epilepsy Diseases 0.000 description 2
- 229940011871 estrogen Drugs 0.000 description 2
- 239000000262 estrogen Substances 0.000 description 2
- 230000001815 facial effect Effects 0.000 description 2
- 230000003890 fistula Effects 0.000 description 2
- 238000005469 granulation Methods 0.000 description 2
- 230000003179 granulation Effects 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 206010025482 malaise Diseases 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 210000002445 nipple Anatomy 0.000 description 2
- 208000037920 primary disease Diseases 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 230000002048 spasmolytic effect Effects 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 238000002560 therapeutic procedure Methods 0.000 description 2
- 201000008827 tuberculosis Diseases 0.000 description 2
- 239000002435 venom Substances 0.000 description 2
- 231100000611 venom Toxicity 0.000 description 2
- 210000001048 venom Anatomy 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 241001580935 Aglossa pinguinalis Species 0.000 description 1
- 201000000736 Amenorrhea Diseases 0.000 description 1
- 206010001928 Amenorrhoea Diseases 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000282994 Cervidae Species 0.000 description 1
- 241000283026 Cervus elaphus Species 0.000 description 1
- 241000283007 Cervus nippon Species 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010051625 Conjunctival hyperaemia Diseases 0.000 description 1
- 206010011224 Cough Diseases 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 208000000059 Dyspnea Diseases 0.000 description 1
- 206010013975 Dyspnoeas Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241001312741 Gekko swinhonis Species 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010061245 Internal injury Diseases 0.000 description 1
- 206010022998 Irritability Diseases 0.000 description 1
- 206010023126 Jaundice Diseases 0.000 description 1
- 206010025421 Macule Diseases 0.000 description 1
- 208000019255 Menstrual disease Diseases 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 206010027514 Metrorrhagia Diseases 0.000 description 1
- 208000007101 Muscle Cramp Diseases 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 1
- 206010068319 Oropharyngeal pain Diseases 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 241000237502 Ostreidae Species 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 201000007100 Pharyngitis Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000000474 Poliomyelitis Diseases 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 208000033240 Progressive symmetric erythrokeratodermia Diseases 0.000 description 1
- 201000004681 Psoriasis Diseases 0.000 description 1
- 241000270273 Ptyas dhumnades Species 0.000 description 1
- 241000555362 Scolopendra subspinipes Species 0.000 description 1
- 208000035286 Spontaneous Remission Diseases 0.000 description 1
- 208000005718 Stomach Neoplasms Diseases 0.000 description 1
- 206010043376 Tetanus Diseases 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 206010046814 Uterine prolapse Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 208000031975 Yang Deficiency Diseases 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- HJYUZIDYQOZTBZ-UHFFFAOYSA-J [K+].S(=O)(=O)([O-])[O-].[Al+3].NN.S(=O)(=O)([O-])[O-] Chemical compound [K+].S(=O)(=O)([O-])[O-].[Al+3].NN.S(=O)(=O)([O-])[O-] HJYUZIDYQOZTBZ-UHFFFAOYSA-J 0.000 description 1
- 210000001015 abdomen Anatomy 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 125000005233 alkylalcohol group Chemical group 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 229910052934 alunite Inorganic materials 0.000 description 1
- 239000010424 alunite Substances 0.000 description 1
- 231100000540 amenorrhea Toxicity 0.000 description 1
- 239000003098 androgen Substances 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000000843 anti-fungal effect Effects 0.000 description 1
- 230000002785 anti-thrombosis Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 208000002399 aphthous stomatitis Diseases 0.000 description 1
- 210000004883 areola Anatomy 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 206010003549 asthenia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 208000010217 blepharitis Diseases 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000021466 carotenoid Nutrition 0.000 description 1
- 150000001747 carotenoids Chemical class 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 230000035606 childbirth Effects 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 239000000084 colloidal system Substances 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000009223 counseling Methods 0.000 description 1
- 238000002425 crystallisation Methods 0.000 description 1
- 230000008025 crystallization Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 230000006866 deterioration Effects 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- 238000003745 diagnosis Methods 0.000 description 1
- 201000001747 discharging ear Diseases 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 229940126534 drug product Drugs 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 201000010582 ecthyma Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000002124 endocrine Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 210000000981 epithelium Anatomy 0.000 description 1
- 201000005619 esophageal carcinoma Diseases 0.000 description 1
- 210000004709 eyebrow Anatomy 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 230000035558 fertility Effects 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 206010017758 gastric cancer Diseases 0.000 description 1
- 210000004907 gland Anatomy 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 150000002333 glycines Chemical class 0.000 description 1
- 239000000745 gonadal hormone Substances 0.000 description 1
- 210000004209 hair Anatomy 0.000 description 1
- 210000004247 hand Anatomy 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 208000014617 hemorrhoid Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 201000001881 impotence Diseases 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 210000000936 intestine Anatomy 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000003141 lower extremity Anatomy 0.000 description 1
- 235000012680 lutein Nutrition 0.000 description 1
- 239000001656 lutein Substances 0.000 description 1
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 description 1
- 229960005375 lutein Drugs 0.000 description 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 230000002175 menstrual effect Effects 0.000 description 1
- 238000000034 method Methods 0.000 description 1
- 230000000116 mitigating effect Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000004767 nitrides Chemical class 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 235000020636 oyster Nutrition 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 239000000825 pharmaceutical preparation Substances 0.000 description 1
- 201000009442 piebaldism Diseases 0.000 description 1
- 239000006187 pill Substances 0.000 description 1
- 239000002574 poison Substances 0.000 description 1
- 230000007096 poisonous effect Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 238000011321 prophylaxis Methods 0.000 description 1
- 230000001047 pyretic effect Effects 0.000 description 1
- 230000002040 relaxant effect Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 206010039073 rheumatoid arthritis Diseases 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 201000005404 rubella Diseases 0.000 description 1
- 239000008971 rukuaixiao Substances 0.000 description 1
- 239000002795 scorpion venom Substances 0.000 description 1
- 210000000582 semen Anatomy 0.000 description 1
- 230000035945 sensitivity Effects 0.000 description 1
- 230000036299 sexual function Effects 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000035943 smell Effects 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 201000011549 stomach cancer Diseases 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 229960001603 tamoxifen Drugs 0.000 description 1
- 210000003813 thumb Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 description 1
- 230000008733 trauma Effects 0.000 description 1
- KPZTWMNLAFDTGF-UHFFFAOYSA-D trialuminum;potassium;hexahydroxide;disulfate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[Al+3].[K+].[O-]S([O-])(=O)=O.[O-]S([O-])(=O)=O KPZTWMNLAFDTGF-UHFFFAOYSA-D 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 231100000925 very toxic Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/58—Reptiles
- A61K35/583—Snakes; Lizards, e.g. chameleons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/62—Leeches; Worms, e.g. cestodes, tapeworms, nematodes, roundworms, earth worms, ascarids, filarias, hookworms, trichinella or taenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/646—Arachnids, e.g. spiders, scorpions, ticks or mites
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/648—Myriapods, e.g. centipedes or millipedes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Developmental Biology & Embryology (AREA)
- Immunology (AREA)
- Virology (AREA)
- Rheumatology (AREA)
- Animal Husbandry (AREA)
- Inorganic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
本发明公开了一种治疗乳腺增生的中药。它由下列重量份的原料药配制而成:15-20份乌蛇、1-3份蜈蚣、1-3份蚯蚓、2-5份五倍子、3-5份鹿角、1-3份斑蝥、1-3份蝎子、10-15份蜂蜡、8-12份白矾。本发明的制备方法:称取上述按重量配比的各原料药,其中,乌蛇、蜈蚣、蚯蚓、五倍子、鹿角、斑蝥、蝎子等制作时需慢火烘焙,烘焙后辗粉备用,蜂蜡、白矾加热溶解后与上述药品充分拌匀即完成制备。本发明组方合理,制备简单,使用方便,疗程短、见效快,疗效好,有效率高,治愈后不复发。
Description
技术领域
本发明涉及一种中药,尤其涉及一种治疗乳腺增生的中药。
背景技术
乳腺增生是指乳腺上皮和纤维组织增生,乳腺组织导管和乳小叶在结构上的退行性病变及进行性结缔组织的生长,其发病原因主要是由于内分泌激素失调。乳腺增生症是女性最常见的乳房疾病,其发病率占乳腺疾病的首位。近些年来该病发病率呈逐年上升的趋势,年龄也越来越低龄化。据调查约有70%~80%的女性都有不同程度的乳腺增生,乳腺增生是一种妇科常见的疾病。多发于30-50岁女性,发病高峰为35-40岁。因为这段时间是女性性机能最旺盛的时期。表现为乳房的不同部位单发或多发地生长一些肿块,质地柔软,边界不清,可活动,常伴有不同程度的疼痛。尤其在月经前、劳累后或是生气(中医称气郁)等情绪波动时,肿块增大,疼痛加重,而在月经后肿块明显缩小,疼痛减轻。疼痛一般是胀痛,很少有刺痛感。应该提醒的是,乳腺增生有转变为乳腺痛的可能,所以如果患乳腺增生时间较长者则应去医院检查,以便及时诊断和治疗。真正的发病原因还不明确,可能与体内激素水平不均衡或乳腺组织对性激素的敏感性较强有关。黄体素分泌减少、雌激素相对增多是本病的重要原因。由于对乳腺增生发生的机理和病因尚无确切了解,部分病人发病后数月至1~2年后常可自行缓解,多不需治疗。症状较明显,病变范围较广泛的病人,可以胸罩托起乳房;口服中药小金丹或消遥散,或5%碘化钾均可缓解症状。使用类似的药物产品较多,如乳块消、乳癖消、天冬素片、平消片、囊癖灵、三苯氧胺等等,但治疗效果并不理想。此外,尚有激素疗法,有人采用雄激素治疗本病,藉以抑制雌激素效应,软化结节,减轻症状;但这种治疗可能加剧人体激素间失衡,不宜常规应用。而中医认为,乳腺增生发病原因多与脏腑机能失调、气血失和有关,病变脏腑责之肝脾,尤其是脾土虚弱之人或过食辛辣肥甘厚味,损伤脾土,而致脾土运化功能失常,聚湿为痰或天生性格内向,情绪压抑,好生闷气或性情急躁、动则易怒或因七情所伤,忧思过度,而致肝失疏泄,郁而成痰等,均可导致痰湿结聚,气血凝滞而形成肿块。
发明内容
本发明要解决的技术问题在于提供一种治疗乳腺增生的中药。它具有化痰软坚,消肿散结,活血化瘀,疏通乳络等疗效,能有效治疗乳腺增生。
为解决上述问题,本发明提供了一种治疗乳腺增生的中药。它由下列重量份的原料药配制而成:15-20份乌蛇、1-3份蜈蚣、1-3份蚯蚓、2-5份五倍子、3-5份鹿角、1-3份斑蝥、1-3份蝎子、10-15份蜂蜡、8-12份白矾。
本发明的制备方法:称取上述按重量配比的各原料药,其中,乌蛇、蜈蚣、蚯蚓、五倍子、鹿角、斑蝥、蝎子等制作时,需慢火烘焙,烘焙后辗粉备用,蜂蜡、白矾加热溶解后与上述药品充分拌匀即完成制备。烘焙、溶解时必须采用桑树枝干作为火源材料,其他材料为火源材料均影响本发明制药效果。
本发明中各原料药组分:乌蛇,又叫乌梢蛇、黑花蛇。性味归经为甘、平,无毒。归肝经。有祛风,活络,定惊的功效。主治顽痹诸风、皮肤不仁、风瘾瘙痒、疥癣、皮肤生癞、眉毛胡须脱落。祛风湿,通经络。治风湿顽痹,肌肤不仁,骨、关节结核,风疹疥癣,麻风,破伤风,小儿麻痹症。乌梢蛇干具有祛风湿、通经络的功效,是治疗风湿性关节炎、中风、口眼歪斜、半身不遂等顽固性疾病的首选天然药材;乌梢蛇肉治病早在李时珍的《本草纲目》中就有记载,主治“诸风顽痹,皮肤不仁,风骚湿疹、疥癣热毒、须眉脱落”等症。乌梢蛇胆有祛风、清热、化痰、明目等功效,可治大风疬疾、木舌胀塞等。蜈蚣,又名叫天龙、百脚虫、少棘蜈蚣等,蜈蚣有毒腺分泌毒液,本身可入药用。具有败毒抭癌、息风解痉、通络止痛、攻毒散结的功效,用于毒蛇咬伤、中风、风湿顽痹,疮疡等。蚯蚓,蚯蚓在中药里叫地龙(开边地龙、广地龙),地龙性寒味咸。其味咸,性寒。功能为清热、镇痉、止喘、利尿。主治高热狂躁、惊风抽搐、头痛目赤、喘息痰热、中风、半身不遂等病证。具有清热止痉,通经活络,清热平喘,利水通淋。内服又可用治高血压,外用可治腮腺炎、慢性下肢溃疡、烫伤。中医验证有明显抑癌作用。《本草纲目》称之为具有通经活络、活血化瘀、预防治疗心脑血管疾病作用。五倍子,又名百虫仓、百药煎、棓子,性味归经:味酸,涩,性寒。归肺、大肠、肾经。功效:敛肺;止汗;涩肠;固精;止血;解毒。主治:肺虚久咳;自汗盗汗;久痢久泻;脱肛;遗精;白浊;各种出血;痈肿疮疖。鹿角,斑龙角、鹿角,为鹿科动物梅花鹿或马鹿已骨化的老角,鹿角含胶质25%,磷酸钙50%-60%,碳酸钙及氮化物。具有抗炎作用,味甘、咸,性温。能补肾阳,活血散瘀;用于肾虚阳痿,腰脊疼痛,阳虚带下,疮肿久不消,行血活血,消瘀,消肿,益肾,主要用于疮疡肿毒,瘀血作痛,虚劳内伤,腰脊疼痛等。 斑蝥,别名斑蚝、花斑毛、斑猫、芫青、花壳虫、章瓦、黄豆虫等,俗称西班牙苍蝇。斑蝥性味辛,热;有大毒。归肝、胃、肾经。具有破血消症,攻毒蚀疮的功能。生斑蝥多外用,毒性较大,以攻毒蚀疮为主。用于瘰疬瘘疮,痈疽肿毒,顽癣瘙痒等证。如治瘰疬结核,疮瘘流脓,久不敛口的生肌干脓散(《验方》);治牛皮癣、白斑的顽癣必效方(《外科正宗》)。米炒后,降低其毒性,矫其气味,可内服。以通经,破症散结为主。用于经闭,症瘕,狂犬咬伤,瘰疬,肝癌,胃癌等证。如治瘀血阻滞,月经闭塞的斑蝥通经丸(《济阴纲目》)。蝎子具有较高的药用价值和食用价值。常用来治疗惊痫、风湿、半身不遂、口眼歪斜、耳聋语涩、手足抽掣等。蝎毒具有祛风、解毒、止痛、通络的功效,对食道癌、肝癌、结肠癌等有一定疗效。蝎子营养价值丰富,是重要的滋补保健品。止痛、散结、通络、祛风解痉、抗血栓、升血糖、抗真菌、抗虫、抗癌防癌。熄风镇痉、消炎攻毒、通络止痛,食之有防病治病、增强免疫力和抗衰老等功能。蜂蜡是工蜂腹部下面四对蜡腺分泌的物质。其主要成分有:酸类、游离脂肪酸、游离脂肪醇和碳水化合物。此外,还有类胡萝卜素、维生素A、芳香物质等。性味归经:甘,微温。功能主治:收涩,敛疮,生肌,止痛,调理。外用于溃疡不敛,臁疮糜烂,创伤,烧、烫伤。白矾为矿物明矾石经加工提炼而成的结晶。主要化学成分为十二水合硫酸铝钾。矿物质中药,外用能解毒杀虫,燥湿止痒;内用止血,止泻,化痰。主治:中风;癫痫;喉痹;疥癣湿疮;痈疽肿毒;水火烫伤;口舌生疮;烂弦风眼;聤耳流脓;鼻中息肉;疮痔疼痛;崩漏;衄血;损伤出血;久泻玖痢;带下阴痒;脱肛;子宫下垂等。白矾性味酸涩,寒,有微毒,可少量食用。故有抗菌作用、收敛作用等,可用做中药。
与现有技术相比,本发明取得的有益效果是:通过将上述各原料药按重量配比合理配伍,具有解毒散结、益气通络、活血化瘀之功效,能够有效治疗乳腺增生、小叶增生、乳腺病等,还能够积极预防乳腺癌变的作用。本发明组方合理,制备简单,使用方便,疗程短、见效快,疗效好,有效率高,治愈后不复发。
具体实施方式
下面结合具体实施例对本发明作进一步详细的说明。
实施例1:一种治疗乳腺增生的中药。它由下列重量份的原料药配制而成:15份乌蛇、1份蜈蚣、1份蚯蚓、2份五倍子、3份鹿角、1份斑蝥、1份蝎子、10份蜂蜡、8份白矾。
本发明的制备方法:将上述各原料药按重量配比称取,其中乌蛇、蜈蚣、蚯蚓、五倍子、鹿角、斑蝥、蝎子等制作时,需慢火烘焙,烘焙后辗粉备用,蜂蜡、白矾加热溶解后与上述药品充分拌匀即完成制备。烘焙、溶解时必须采用桑树枝干作为火源材料,其他材料为火源材料均影响本发明制药效果。
本发明的用法及用量:以红粘谷酒为药引(50克为宜),一日二次,每次8-12克,18-20天为一疗程,前三天发汗排毒,轻症患者一般1-2个疗程康复,重症患者一般3-4个疗程康复。本发明治愈后不易复发。服药期间忌食辛辣食物和豆类食品。
实施例2:一种治疗乳腺增生的中药。它由下列重量份的原料药配制而成:17.5份乌蛇、2份蜈蚣、2份蚯蚓、3.5份五倍子、4份鹿角、2份斑蝥、2份蝎子、12.5份蜂蜡、10份白矾。
本发明的制备方法:将上述各原料药按重量配比称取,其中乌蛇、蜈蚣、蚯蚓、五倍子、鹿角、斑蝥、蝎子等制作时,需慢火烘焙,烘焙后辗粉备用,蜂蜡、白矾加热溶解后与上述药品充分拌匀即完成本中药制备。烘焙、溶解时必须采用桑树枝干作为火源材料,其他材料为火源材料均影响本发明制药效果。
本发明的用法及用量:以红粘谷酒为药引(50克为宜),一日二次,每次8-12克,18-20天为一疗程,前三天发汗排毒,轻症患者一般1-2个疗程康复,重症患者一般3-4个疗程康复。本发明治愈后不易复发。服药期间忌食辛辣食物和豆类食品。
实施例3:一种治疗乳腺增生的中药。它由下列重量份的原料药配制而成:20份乌蛇、3份蜈蚣、3份蚯蚓、5份五倍子、5份鹿角、3份斑蝥、3份蝎子、15份蜂蜡、12份白矾。
本发明的制备方法:将上述各原料药按重量配比称取,其中乌蛇、蜈蚣、蚯蚓、五倍子、鹿角、斑蝥、蝎子等制作时,需慢火烘焙,烘焙后辗粉备用;蜂蜡、白矾加热溶解后与上述药品充分拌匀即完成本中药制备。烘焙、溶解时必须采用桑树枝干作为火源材料,其他材料为火源材料均影响本发明制药效果。
本发明的用法及用量:以红粘谷酒为药引(50克为宜),一日二次,每次8-12克,18-20天为一个疗程,前三天发汗排毒,轻症患者一般1-2个疗程康复,重症患者一般3-4个疗程康复。本发明治愈后不易复发。注意服药期间忌食辛辣食物和豆类食品。
上面结合具体实施方式对本发明作了详细说明,但是本发明并不限于上述实施方式,在本领域普通技术人员所具备的知识范围内,还可以对其做出种种变化。
本发明临床观察的结果如下:
典型病例:
病例一 陈某,女,39岁,2000年患乳腺小叶增生,多年奔走于省市各医院进行中西医治疗,治疗后当时效果比较明显,但很容易复发,患者心理压力非常大。后来该患者通过多方打听于2007年2月前来我处就诊,询问得知该患者家庭不和睦、脾气暴躁、从事过劳工作、生活压力大。就诊时乳房有拇指般大小肿块,查看该患者X光片、病例后确诊为患乳腺小叶增生。患者服用本发明的中药2个疗程后治愈至今未复发。
病例二 王某,女,31岁,患者自述,该患者2009年30岁第一次生育,属于晚婚晚育,因小孩出生5天后黄胆住院5天,后又因小孩肺炎住院7天,导致患者回奶无法母乳喂养。一段时间后患者出现乳房涨痛、有肿块、月经不调等症状。患者采用西医治疗效果不明显,后于2012年7月来我处就诊,查看患者病例和X光片确诊为乳腺增生后,开处方,患者服用本发明的中药1个疗程后治愈,至今未复发。
病例三 刘某,女,53岁,患乳腺腺病。患者自述,该患者1998年患乳腺小叶增生,后经过长期中西治疗后不但无法痊愈,且病情不继恶化。2010年经省大医院确诊为乳腺腺病并呈现恶性发展势头,患者心理压力很大,甚至一度消极治疗。后经人介绍于2011年1月前来我处就诊。查阅病例,进行心理疏导后,结合患者实际情况开处方,患者服用本发明的中药3个疗程后治愈,至今未复发。
病例四 陈某,男,33岁,患男性乳腺增生病。患者自述,该患者2006年开始出现乳头和乳晕增大,局部有隐痛,有触痛感,患者刚开始没有注意治疗,一段时间后该患者出现挤压乳头时有少量白色分泌物溢出,痛感增强等症状。经省医院确诊为男性乳腺增生,辗转多地治疗后均无明显效果。2008年该患者经人介绍前来我处治疗。查阅患者病历后,结合患者实际病情开处方,患者服用本发明的中药2个疗程后治愈,回访至今未复发。
病例五 李某,女,28岁,患乳腺增生病。患者自述,该患者2010年开始出现周期性乳房胀痛,月经后疼痛一般自行减少或消失,半年后该患者出现明显乳房胀痛且周期较长。经该市医院确诊为患乳腺增生病。患者刚开始采用西医治疗,后采用中医治疗,治疗效果后病情反反复复,给患者造成很大心理压力。2012年经人介绍前来我处治疗。查阅患者病历后,结合患者实际病情开处方,采用上述配制方法配制中药,按上述方法服用。患者服用本发明的中药2个疗程后治愈,回访至今未复发。
Claims (6)
1.一种治疗乳腺增生的中药,它由下列重量份的原料药配制而成:15-20份乌蛇、1-3份蜈蚣、1-3份蚯蚓、2-5份五倍子、3-5份鹿角、1-3份斑蝥、1-3份蝎子、10-15份蜂蜡、8-12份白矾。
2.如权利要求1所述的治疗乳腺增生的中药,它由下列重量份的原料药配制而成:15份乌蛇、1份蜈蚣、1份蚯蚓、2份五倍子、3份鹿角、1份斑蝥、1份蝎子、10份蜂蜡、8份白矾。
3.如权利要求1所述的治疗乳腺增生的中药,它由下列重量份的原料药配制而成:17.5份乌蛇、2份蜈蚣、2份蚯蚓、3.5份五倍子、4份鹿角、2份斑蝥、2份蝎子、12.5份蜂蜡、10份白矾。
4.如权利要求1所述的治疗乳腺增生的中药,它由下列重量份的原料药配制而成:20份乌蛇、3份蜈蚣、3份蚯蚓、5份五倍子、5份鹿角、3份斑蝥、3份蝎子、15份蜂蜡、12份白矾。
5.如权利要求1至4中任一项所述的治疗乳腺增生的中药的制备方法,其特征在于:所述制备方法为将上述各原料药按重量配比称取,其中乌蛇、蜈蚣、蚯蚓、五倍子、鹿角、斑蝥、蝎子等制作时,需慢火烘焙,烘焙后辗粉备用,蜂蜡、白矾加热溶解后与上述药品充分拌匀即完成制备。
6.如权利要求5所述的制备方法,其特征在于:烘焙、溶解时采用桑树枝干作为火源材料。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410700984.4A CN104434998A (zh) | 2014-11-28 | 2014-11-28 | 一种治疗乳腺增生的中药 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410700984.4A CN104434998A (zh) | 2014-11-28 | 2014-11-28 | 一种治疗乳腺增生的中药 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN104434998A true CN104434998A (zh) | 2015-03-25 |
Family
ID=52882260
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410700984.4A Pending CN104434998A (zh) | 2014-11-28 | 2014-11-28 | 一种治疗乳腺增生的中药 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN104434998A (zh) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105616453A (zh) * | 2016-01-27 | 2016-06-01 | 张永锋 | 一种中药组合物及其应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1129122A (zh) * | 1995-02-13 | 1996-08-21 | 张驰 | 治疗乳腺增生及乳痛症的乳安汤剂 |
CN103110891A (zh) * | 2013-02-06 | 2013-05-22 | 河南中医学院 | 一种治疗乳腺增生及乳腺癌的中药 |
-
2014
- 2014-11-28 CN CN201410700984.4A patent/CN104434998A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1129122A (zh) * | 1995-02-13 | 1996-08-21 | 张驰 | 治疗乳腺增生及乳痛症的乳安汤剂 |
CN103110891A (zh) * | 2013-02-06 | 2013-05-22 | 河南中医学院 | 一种治疗乳腺增生及乳腺癌的中药 |
Non-Patent Citations (3)
Title |
---|
张前德等: "《慢性病:中医临床特色与优势》", 31 July 2013, 江苏科学技术出版社 * |
林新等: "乳癖散结胶囊治疗乳腺增生69例", 《陕西中药》 * |
潘华等: "乳癖消片治疗乳腺增生症66例", 《陕西中医》 * |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105616453A (zh) * | 2016-01-27 | 2016-06-01 | 张永锋 | 一种中药组合物及其应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN110393781B (zh) | 一种治疗甲状腺结节的纯中药制剂及制备方法 | |
CN104758844B (zh) | 一种治疗卵巢早衰的中药 | |
CN106177725A (zh) | 一种治疗乳腺疾病的膏药组合物、用途及其制备方法 | |
WO2016066058A1 (zh) | 一种治疗乳腺炎的外敷中药组合物 | |
CN105641256A (zh) | 一种治疗儿童睑板腺囊肿的中药组合物 | |
CN103083573B (zh) | 一种治疗酒精性脂肪肝的中药 | |
CN104434998A (zh) | 一种治疗乳腺增生的中药 | |
CN104056128A (zh) | 一种治疗溃疡性结肠炎的中药配方 | |
CN103920126B (zh) | 一种用于类风湿性膝关节炎的贴剂及其制备方法 | |
CN104383453B (zh) | 治疗脑外伤后狂躁症的中药 | |
CN103877384B (zh) | 一种治疗直肠癌的中药制剂及制备方法 | |
CN106617053A (zh) | 一种防治前列腺炎及前列腺增生的保健食品及制备方法 | |
CN104845832A (zh) | 一种滋补药酒 | |
CN104474455A (zh) | 一种治疗甲亢的中药 | |
CN116211983B (zh) | 一种治疗原发性痛经的天麻组方药及其应用 | |
CN103127376A (zh) | 一种治疗直肠炎的中药组合物 | |
CN103285339B (zh) | 一种治疗骨痛病的外用药物 | |
CN106975044A (zh) | 一种治疗结石的药物及其制备方法和应用 | |
CN107019780A (zh) | 一种治疗乳腺增生的中药组合物 | |
CN106266704A (zh) | 治疗肠胃炎的中药组合物及制备方法 | |
CN108324908B (zh) | 用于治疗肝胆结石的中药组合物和用于治疗肝胆结石的药剂 | |
CN104042875B (zh) | 一种中药组合物及其制备方法和用途 | |
CN104173918A (zh) | 治疗原发性痛经的中药组合物 | |
CN102210828B (zh) | 治疗牛皮癣的中药胶囊 | |
CN113842422A (zh) | 一种治疗子宫肌瘤药物及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20150325 |
|
RJ01 | Rejection of invention patent application after publication |